The tumor mutational landscape of BRCA2-deficient primary and metastatic prostate cancer
The tumor mutational landscape of BRCA2-deficient primary and metastatic prostate cancer
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Carriers of germline
BRCA2
pathogenic sequence variants have elevated aggressive prostate cancer risk and are candidates for precision oncology treatments. We examined whether
BRCA2
-deficient (
BRCA2
d
) prostate tumors have distinct genomic alterations compared with
BRCA2
-intact (
BRCA2
i
) tumors. Among 2536...
Alternative Titles
Full title
The tumor mutational landscape of BRCA2-deficient primary and metastatic prostate cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e8bd40b686474509a6110e6ca54a55c3
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e8bd40b686474509a6110e6ca54a55c3
Other Identifiers
ISSN
2397-768X
E-ISSN
2397-768X
DOI
10.1038/s41698-022-00284-6